Drug Shortage Report for DEXILANT
| Report ID | 152943 |
| Drug Identification Number | 02354969 |
| Brand name | DEXILANT |
| Common or Proper name | Dexlansoprazole delayed release capsules |
| Company Name | TAKEDA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXLANSOPRAZOLE |
| Strength(s) | 60MG |
| Dosage form(s) | CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL NASOGASTRIC ORAL NASOGASTRIC |
| Packaging size | Bottles of 90's |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-01-17 |
| Actual start date | 2022-01-17 |
| Estimated end date | 2022-02-28 |
| Actual end date | 2022-02-25 |
| Shortage status | Resolved |
| Updated date | 2022-02-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-02-26 | English | Compare |
| v4 | 2022-02-25 | French | Compare |
| v3 | 2022-02-25 | English | Compare |
| v2 | 2022-01-17 | French | Compare |
| v1 | 2022-01-17 | English | Compare |
Showing 1 to 5 of 5